Overview

Reify Health focuses on improving the clinical trial process by addressing the challenges of patient recruitment and enrollment. Its main product, StudyTeam, is a software platform that helps pharmaceutical companies, biotech firms, and contract research organizations (CROs) manage and speed up patient enrollment in clinical trials. StudyTeam provides real-time access to pre-screening and enrollment data, allowing sponsors to adjust their strategies and timelines proactively, making the enrollment process more predictable and efficient. Unlike many competitors, Reify Health operates on a subscription-based software-as-a-service (SaaS) model, which offers clients ongoing access to the platform for a recurring fee. The goal of Reify Health is to reduce the time and costs associated with patient enrollment, ultimately enhancing the success rates of clinical trials.

Simplify's Take

What believers are saying

• Increased focus on diversity in trials aligns with Reify's BRIDGE initiative.
• AI integration in trial management offers potential improvements in recruitment and data analysis.
• Decentralized clinical trials allow for more flexible, patient-centric trial management.

What critics are saying

• Emerging competitors with innovative features threaten Reify Health's market share.
• Departure of key personnel like Macy may disrupt ongoing projects and innovation.
• Layoffs at Care Access suggest potential internal financial or operational challenges.

What makes Reify Health unique

• Reify Health's StudyTeam accelerates clinical trial enrollment, reducing time and costs.
• The platform offers real-time data access, enhancing trial predictability and efficiency.
• Reify Health addresses diversity in trials with its BRIDGE initiative, improving representation.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$477.9M

Above

Industry Average

Funded Over

6 Rounds

Notable Investors:

Coatue ManagementBattery Ventures

Notable Investors:

Coatue ManagementBattery Ventures

$220,000,000

Series D

Apr 2022

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.

Series D Funding Comparison

Above Average

Industry standards

Ind Avg. $77M

$49M

$50M

$70M

$80M

$100M

$220M

View all funding stages